Gelareh Farshid (@drgfarshid) profile picture

Gelareh Farshid

@drgfarshid

Pathologist at Royal Adelaide Hospital | Professor @UniofAdelaide | Interested in breast & soft tissue pathology, breast cancer screening & digital pathology

Joined June 2017
  • Tweets58
  • Following294
  • Followers154
1Media
Photo by Gelareh Farshid (@drgfarshid)
Great session at the ISBpath in Baltimore
5
160
Intubated ICU patients using VR to take a short immersive vacation while getting some physical exercise in. Source: darlan nitz
137
1,746
308
7,620
1,029,776
We have uncovered a new molecular mechanism responsible for nearly one-third of sporadic schwannomas – recurrent insertion/deletion mutations in 𝑆𝑂𝑋10. doi.org/10.1093/neuonc/noad1…
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene...

Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene...

AbstractBackground. Schwannomas are common peripheral nerve sheath tumors that can cause severe morbidity given their stereotypic intracranial and paraspin

academic.oup.com
8
24
5
93
12,312
We're pleased to announce our Impact Factor for @Pathology_RCPA is 4.5, with a ranking of 18/76 among the world’s #pathology journals. Thank you and kudos to our authors, peer reviewers, editorial board and Editor-in-Chief @ProfRScolyerMIA. Source: Clarivate 2023 #JCR2023
Image from Pathology Journal (@Pathology_RCPA)
1
9
38
7,032
Hi all! Feeling great in neuro ICU at #RPAH/@SydneyLHD. Thanks so much to my friend & colleague Dr Brindha Shivalingam & team for meeting with my wife Dr Katie Nicoll & @ProfGLongMIA yesterday & for operating on me today! Thanks to friends & colleagues around world & @MelanomaAus
Image from Professor Richard Scolyer AO (@ProfRAScolyer)
Image from Professor Richard Scolyer AO (@ProfRAScolyer)
Image from Professor Richard Scolyer AO (@ProfRAScolyer)
Image from Professor Richard Scolyer AO (@ProfRAScolyer)
45
25
4
494
36,175
smh.com.au/politics/federal/… It can be done “Progress is not linear. Gender equality does not happen unless we measure it and report on it, and ensure we guard against conscious and unconscious bias. @SaraEWobker @LJTafeMD @GuptaRuta @FionaMacPath @dahlstrom_jane @priyanthi_k2017
Women get greater share of Order of Australia honours for the first time

Women get greater share of Order of Australia honours for the first time

Long criticised for being dominated by men, the Order of Australia has achieved gender parity for the first time, but Governor-General David Hurley says lifting Indigenous and multicultural represe...

smh.com.au
1
3
8
771
Thankyou AProf Cooper for presenting our poster at the @IAP_AUS showing underrepresentation of women in leadership positions, academia and awards. It is great to stimulate discussions about this @FionaMacPath @CArnold_Coach @Sara_Jiang @GuptaRuta @SaraEWobker @Vik_deshpandeMD
Image from Catriona Mckenzie (@CatrionaMckenz5)
12
25
4,334
Who dares answer these questions? Deep soft tissue tumor of the foot in a 50+ male. Low power: partly nested to fascicular with transecting fibrous bands. High power, the cells are uniform, ovoid with pale to clear cytoplasm and prominent nucleoli.
Image from Scott Kilpatrick, MD (@ScottBikeethan)
Image from Scott Kilpatrick, MD (@ScottBikeethan)
Image from Scott Kilpatrick, MD (@ScottBikeethan)
12
55
141
21,099
Gelareh Farshid retweeted
ISBP (@TheISBP) profile picture
ISBP@TheISBP29 Jun 2022
Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial ascopubs.org/doi/10.1200/JCO…
Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemother...

Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemother...

PURPOSECombining standard of care (pertuzumab-trastuzumab [PH], chemotherapy) with cancer immunotherapy may potentiate antitumor immunity, cytotoxic activity, and patient outcomes in high-risk, human...

ascopubs.org
1
Gelareh Farshid retweeted
ISBP (@TheISBP) profile picture
ISBP@TheISBP24 Feb 2020
47 years old woman with palpable left breast mass, 4 cm. Left breast lumpectomy. Mass forming pseudoangiomatous stromal hyperplasia (PASH). #breastpath @MSKPathology @EdiBrogi @fcschmitt @SchnittStuart @CollinsLauraC @jennpincus @LizaMQuintana @rovingatuscap @HannahYWen
Image from ISBP (@TheISBP)
Image from ISBP (@TheISBP)
Image from ISBP (@TheISBP)
31
59
Check it out! This new issue of @SurgicalClinics on #sarcoma is out! See here a recap of the whole table of contents! The Ever-Evolving Landscape of Sarcomas: A 2022 Update on This Complex Family of Diseases surgonc.theclinics.com/artic… @chandrajitraut @timpawlik @ctosociety (1/15)
Image from Alessandro Gronchi (@alegronchi)
2
56
6
100
Accepting someone for who they are means accepting the choices they made that, in turn, made them. Even if you might not understand those choices. Even if you might not have made the same choices. You can still accept them.
7
36
1
247
Gelareh Farshid retweeted
ISBP (@TheISBP) profile picture
ISBP@TheISBP5 Jun 2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM nejm.org/doi/full/10.1056/NE… @fcschmitt @drgfarshid @EdiBrogi @DrKimAllison
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM

Among breast cancers without human epidermal growth factor receptor 2 (HER2) amplification, overexpression, or both, a large proportion express low levels of HER2 that may be targetable. Currently ...

nejm.org
3
4
60 yo man with 2 cm breast mass. One of the BEST examples ever! Can you make diagnosis from one pic, or is it #TooCloseToDiagnose? WSI digital slide: kikoxp.com/posts/4600. Answer & video: kikoxp.com/posts/9332. #pathologists #pathology #pathTwitter #BSTpath #breastpath
Image from Jerad Gardner, MD (@JMGardnerMD)
10
32
89
Gelareh Farshid retweeted
ISBP (@TheISBP) profile picture
ISBP@TheISBP22 Apr 2022
Mastectomy post neoadjuvant therapy. Extensive LVI mimicking DCIS. IHC for D2-40 (left) and p63 (right). #breastpath @EdiBrogi @fcschmitt @CollinsLauraC @SchnittStuart @LizaMQuintana @AGrabenstetter @mkw_MD @MSKPathology @drgfarshid @HannahYWen
Image from ISBP (@TheISBP)
Image from ISBP (@TheISBP)
Image from ISBP (@TheISBP)
Image from ISBP (@TheISBP)
22
51
A new @ASCO guideline update: Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative #BreastCancer ➡️ fal.cn/3nLKz #JCO #bcsm
Image from Journal of Clinical Oncology (@JCO_ASCO)
1
51
5
73
Gelareh Farshid retweeted
ISBP (@TheISBP) profile picture
ISBP@TheISBP20 Mar 2022
A huge Thank You to our outstanding speakers Dr. Laura Collins, Dr. Patricia Ganz, Dr. Torsten Nielsen @TheISBP companion meeting @TheUSCAP. @CollinsLauraC @LizaMQuintana @EdiBrogi @fcschmitt @drgfarshid @HannahYWen @SchnittStuart
Image from ISBP (@TheISBP)
Image from ISBP (@TheISBP)
Image from ISBP (@TheISBP)
4
22
Pathogenesis of Triple-Negative Breast Cancer #TNBC @TNBCFoundation @BreastCaupdates @BCRFcure @MSKCC_BreastCA pubmed.ncbi.nlm.nih.gov/3507…
Pathogenesis of Triple-Negative Breast Cancer - PubMed

Pathogenesis of Triple-Negative Breast Cancer - PubMed

Triple-negative breast cancer (TNBC) encompasses a heterogeneous group of fundamentally different diseases with different histologic, genomic, and immunologic profiles, which are aggregated under...

pubmed.ncbi.nlm.nih.gov
3
1
6
"Do you think it's possible to predict, based on the genomic profile of an individual tumor, which organs it might metastasize to?" Data from 25,000 patients published in @CellPressNews is helping MSK scientists answer this & many other important Qs. bit.ly/3uoSXqC
13
1
30
Gelareh Farshid retweeted
Alcidion (@alcidion) profile picture
Alcidion@alcidion3 Feb 2022
Enjoying the broad ranging & thought provoking discussion about Evolving Models of Care at @THTpodcast with @malcolmp and @SydneyLHD Richard Taggart
Image from Alcidion (@alcidion)
1
9
Load more